AI Transparency Report
Alzheimers Disease And Related Disorders New York City Inc (ADRDA NYC) demonstrates a generally stable financial position with consistent revenue generation over the past decade, though with some fluctuations. In the most recent filing (202306), the organization reported revenues of $5,564,426 against expenses of $5,197,716, indicating a surplus for the period. This positive trend is also observed in 202206 and 202106, reversing a period of deficits seen from 201406 to 202006 where expenses frequently exceeded revenue. The organization's assets have shown growth in recent years, increasing from $3,194,996 in 202006 to $7,561,215 in 202306, suggesting improved financial health and capacity.
Spending efficiency appears to be a focus, with the organization consistently reporting 0% officer compensation across all available filings, which is a strong indicator of resource allocation towards its mission rather than executive salaries. While specific program, administrative, and fundraising expense breakdowns are not provided in the summary data, the overall trend of managing expenses within or close to revenue levels in recent years suggests a move towards greater efficiency. The organization's NTEE code G83 (Voluntary Health Associations & Medical Disciplines) aligns with its mission, and the consistent filing of IRS Form 990s demonstrates a commitment to regulatory transparency.
However, the organization experienced significant periods of operating deficits, particularly from 2014 to 2020, where expenses consistently outstripped revenue. For example, in 201706, expenses were $9,553,209 against revenues of $6,997,404. While recent years show a positive turnaround, this historical pattern warrants attention to ensure long-term financial sustainability. The growth in assets and recent surpluses are positive signs, but continued vigilance on expense management relative to revenue is crucial for sustained financial health and mission impact.